Cervical precancer and cancer incidence among insured women with and without HIV in South Africa
© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC..
HIV infection increases the risk of developing cervical cancer; however, longitudinal studies in sub-Saharan Africa comparing cervical cancer rates between women living with HIV (WLWH) and women without HIV are scarce. To address this gap, we compared cervical precancer and cancer incidence rates between WLWH and women without HIV in South Africa using reimbursement claims data from a medical insurance scheme from January 2011 to June 2020. We used Royston-Parmar flexible parametric survival models to estimate cervical precancer and cancer incidence rates as a continuous function of age, stratified by HIV status. Our study population consisted of 518 048 women, with exclusions based on the endpoint of interest. To analyse cervical cancer incidence, we included 517 312 women, of whom 564 developed cervical cancer. WLWH had an ~3-fold higher risk of developing cervical precancer and cancer than women without HIV (adjusted hazard ratio for cervical cancer: 2.99; 95% confidence interval [CI]: 2.40-3.73). For all endpoints of interest, the estimated incidence rates were higher in WLWH than women without HIV. Cervical cancer rates among WLWH increased at early ages and peaked at 49 years (122/100 000 person-years; 95% CI: 100-147), whereas, in women without HIV, incidence rates peaked at 56 years (40/100 000 person-years; 95% CI: 36-45). Cervical precancer rates peaked in women in their 30s. Analyses of age-specific cervical cancer rates by HIV status are essential to inform the design of targeted cervical cancer prevention policies in Southern Africa and other regions with a double burden of HIV and cervical cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:154 |
---|---|
Enthalten in: |
International journal of cancer - 154(2024), 2 vom: 15. Jan., Seite 273-283 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fernández Villalobos, Nathalie Verónica [VerfasserIn] |
---|
Links: |
---|
Themen: |
HIV |
---|
Anmerkungen: |
Date Completed 23.11.2023 Date Revised 18.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/ijc.34707 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361564341 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM361564341 | ||
003 | DE-627 | ||
005 | 20240218231853.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ijc.34707 |2 doi | |
028 | 5 | 2 | |a pubmed24n1298.xml |
035 | |a (DE-627)NLM361564341 | ||
035 | |a (NLM)37658695 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fernández Villalobos, Nathalie Verónica |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cervical precancer and cancer incidence among insured women with and without HIV in South Africa |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.11.2023 | ||
500 | |a Date Revised 18.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. | ||
520 | |a HIV infection increases the risk of developing cervical cancer; however, longitudinal studies in sub-Saharan Africa comparing cervical cancer rates between women living with HIV (WLWH) and women without HIV are scarce. To address this gap, we compared cervical precancer and cancer incidence rates between WLWH and women without HIV in South Africa using reimbursement claims data from a medical insurance scheme from January 2011 to June 2020. We used Royston-Parmar flexible parametric survival models to estimate cervical precancer and cancer incidence rates as a continuous function of age, stratified by HIV status. Our study population consisted of 518 048 women, with exclusions based on the endpoint of interest. To analyse cervical cancer incidence, we included 517 312 women, of whom 564 developed cervical cancer. WLWH had an ~3-fold higher risk of developing cervical precancer and cancer than women without HIV (adjusted hazard ratio for cervical cancer: 2.99; 95% confidence interval [CI]: 2.40-3.73). For all endpoints of interest, the estimated incidence rates were higher in WLWH than women without HIV. Cervical cancer rates among WLWH increased at early ages and peaked at 49 years (122/100 000 person-years; 95% CI: 100-147), whereas, in women without HIV, incidence rates peaked at 56 years (40/100 000 person-years; 95% CI: 36-45). Cervical precancer rates peaked in women in their 30s. Analyses of age-specific cervical cancer rates by HIV status are essential to inform the design of targeted cervical cancer prevention policies in Southern Africa and other regions with a double burden of HIV and cervical cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV | |
650 | 4 | |a South Africa | |
650 | 4 | |a uterine cervical dysplasia | |
650 | 4 | |a uterine cervical neoplasms | |
700 | 1 | |a Ruffieux, Yann |e verfasserin |4 aut | |
700 | 1 | |a Haas, Andreas D |e verfasserin |4 aut | |
700 | 1 | |a Chinogurei, Chido |e verfasserin |4 aut | |
700 | 1 | |a Cornell, Morna |e verfasserin |4 aut | |
700 | 1 | |a Taghavi, Katayoun |e verfasserin |4 aut | |
700 | 1 | |a Egger, Matthias |e verfasserin |4 aut | |
700 | 1 | |a Folb, Naomi |e verfasserin |4 aut | |
700 | 1 | |a Maartens, Gary |e verfasserin |4 aut | |
700 | 1 | |a Rohner, Eliane |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d 1966 |g 154(2024), 2 vom: 15. Jan., Seite 273-283 |w (DE-627)NLM000004383 |x 1097-0215 |7 nnns |
773 | 1 | 8 | |g volume:154 |g year:2024 |g number:2 |g day:15 |g month:01 |g pages:273-283 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/ijc.34707 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 154 |j 2024 |e 2 |b 15 |c 01 |h 273-283 |